Highly interesting events on transglutaminase, celiac disease, thromoprophylaxis or other related topics.
Please contact us in advance to make an appointment to meet at the venue.



BIO-Europe
06. November 2017 - 08. November 2017
Location Berlin, Germany
Comment Meet Dr. Ralf Pasternack at the business partnering conference!
 
 
MEDICA
13. November 2017 - 16. November 2017
Location Düsseldorf, Germany
External Link MEDICA
Comment Meet Dr. Martin Hils and Dr. Ralf Pasternack at the venue!
 
 
Gordon Research Conference on: Transglutaminases in Human Disease Processes
16. June 2018 - 17. June 2018
Location Les Diablerets, Switzerland
External Link GRC
Comment Meet Dr. Martin Hils and Dr. Ralf Pasternack at the GRC 2018!
 
 

Products

  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.
    All products

News  

  • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
    Read more All news
  • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    Read more All news
  • Press Release: Dr. Falk Pharma GmbH and Zedira enter a phase 1b clinical trial for a celiac disease drug
    Read more All news
  • Zedira publication: Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope
    Read more All news
  • Press release: Additional subsidy funding for clinical development of a celiac disease drug
    Read more All news
  • Pressemitteilung: Zusätzliche Fördermittel für die klinische Entwicklung eines Zöliakie-Medikamentes
    Read more All news
  • Press Release: Cooperation between Zedira and Cardiff University - Transglutaminase 6 is the focus of new research into ataxia
    Read more All news
  • Press Release: Dr. Falk Pharma and Zedira enter phase I clinical trials for a celiac disease drug
    Read more All news
  • Press release: Zedira receives further funding to develop Factor XIIIa-blockers for safe anticoagulation
    Read more All news

Blog  

Events  

  • BIO-Europe

    06.11.2017 - 08.11.2017
    Berlin, Germany

    All events
  • MEDICA

    13.11.2017 - 16.11.2017
    Düsseldorf, Germany

    All events
  • Gordon Research Conference on: Transglutaminases in Human Disease Processes

    16.06.2018 - 17.06.2018
    Les Diablerets, Switzerland

    All events